Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001640334-19-000219
Filing Date
2019-02-11
Accepted
2019-02-11 17:02:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D inmb_sc13d.htm SC 13D 28258
  Complete submission text file 0001640334-19-000219.txt   29522
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90859 | Film No.: 19586319
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 476 MASSACHUSETTS AVE, UNIT 2 BOSTON MA 02118
Business Address
Tesi Raymond Joseph (Filed by) CIK: 0001767280 (see all company filings)

Type: SC 13D